Introduction: Spinal cord (SC) pathology is strongly associated with disability in multiple sclerosis (MS). We aimed to evaluate the association between focal and diffuse SC abnormalities and spinal cord volume and to assess their contribution to physical disability in MS patients. Methods: This large sample-size cross-sectional study investigated 1,249 patients with heterogeneous MS phenotypes. Upper cervical-cord cross-sectional area (MUCCA) was calculated on an axial 3D-T2w-FatSat sequence acquired at 3T using a novel semiautomatic edge-finding tool. SC images were scored for the presence of sharply demarcated hyperintense areas (focal lesions) and homogenously increased signal intensity (diffuse changes). Patients were dichotomized according EDSS in groups with mild (EDSS up to 3.0) and moderate (EDSS ≥ 3.5) physical disability. Analysis of covariance was used to identify factors associated with dichotomized MUCCA. In binary logistic regression, the SC imaging parameters were entered in blocks to assess their individual contribution to risk of moderate disability. In order to assess the risk of combined SC damage in terms of atrophy and lesional pathology on disability, secondary analysis was carried out where patients were divided into four categories (SC phenotypes) according to median dichotomized MUCCA and presence/absence of focal and/or diffuse changes. Results: MUCCA was strongly associated with total intracranial volume, followed by presence of diffuse SC pathology, and disease duration. Compared to the reference group (normally appearing SC, MUCCA>median), patients with the most severe SC changes (SC affected with focal and/or diffuse lesions, MUCCA

Department of Neurology 1st Faculty of Medicine Center of Clinical Neuroscience Charles University and General University Hospital Prague Prague Czechia

Department of Radiology Charles University Prague 1st Faculty of Medicine and General University Hospital Prague Czechia

Endowment Fund IMPULS Prague Czechia

See more in PubMed

Casserly C, Seyman EE, Alcaide-Leon P, Guenette M, Lyons C, Sankar S, et al. . Spinal cord atrophy in multiple sclerosis: a systematic review and meta-analysis. J Neuroimag. (2018) 28:556–86. 10.1111/jon.12553 PubMed DOI

Tsagkas C, Magon S, Gaetano L, Pezold S, Naegelin Y, Amann M, et al. . Spinal cord volume loss. Neurology. (2018) 91:e349–58. 10.1212/WNL.0000000000005853 PubMed DOI

Kearney H, Miller DH, Ciccarelli O. Spinal cord MRI in multiple sclerosis-diagnostic, prognostic and clinical value. Nat Rev Neurol. (2015) 11:327–38. 10.1038/nrneurol.2015.80 PubMed DOI

Lukas C, Sombekke MK, Bellenberg B, Hahn HK, Popescu V, Bendfeldt K, et al. . Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: mr imaging findings in a large cohort of patients. Radiology. (2013) 269:542–52. 10.1148/radiol.13122566 PubMed DOI

Kearney H, Rocca MA, Valsasina P, Balk L, Sastre-Garriga J, Reinhardt J, et al. . Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration. Multiple Sclerosis. (2014) 20:72–80. 10.1177/1352458513492245 PubMed DOI PMC

Daams M, Weiler F, Steenwijk MD, Hahn KK, Geurts JG, Vrenken H, et al. . Mean upper cervical cord area (MUCCA) measurement in long-standing multiple sclerosis: relation to brain findings and clinical disability. Multiple Sclerosis J. (2014) 20:1860–5. 10.1177/1352458514533399 PubMed DOI

Rovaris M, Judica E, Ceccarelli A, Ghezzi A, Martinelli V, Comi G, et al. . Absence of diffuse cervical cord tissue damage in early, non-disabling relapsing-remitting ms: a preliminary study. Multiple Sclerosis. (2008) 14:853–6. 10.1177/1352458507088103 PubMed DOI

Bot JC, Barkhof F, Polman CH, Lycklamaà Nijeholt GJ, de Groot V, Bergers E, et al. . Spinal cord abnormalities in recently diagnosed ms patients: added value of spinal MRI examination. Neurology. (2004) 62:226–33. 10.1212/WNL.62.2.226 PubMed DOI

Lycklama À Nijeholt GJ, Barkhof F, Scheltens P, Castelijns PA, Adèr H, Van Waesberghe JH, et al. MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability. Am J Neuroradiol. (1997) 18:1041–8. PubMed PMC

Nijeholt GJ, Van Walderveen MA, Castelijns JA, Van Waesberghe JH, Polman C, Scheltens P, et al. . Brain and spinal cord abnormalities in multiple sclerosis: correlation between MRI parameters, clinical subtypes and symptoms. Brain. (1998) 121(Pt 4):687–97. 10.1093/brain/121.4.687 PubMed DOI

Bonek R, Orlicka K, Maciejek Z. Demyelinating lesions in the cervical cord in multiple sclerosis 10 years after onset of the disease. correlation between MRI parameters and clinical course. Neurol Neurochir Pol. (2007) 41:229–33. PubMed

Kidd D, Thorpe JW, Thompson AJ, Kendall B, Moseley I, MacManus DG, et al. Spinal cord MRI using multi-array coils and fast spin echo. Find Multiple Sclerosis. (1993) 43:2625–31. 10.1212/WNL.43.12.2625 PubMed DOI

Stankiewicz JM, Neema M, Alsop DC, Healy BC, Arora A, Buckle GJ, et al. . Spinal cord lesions and clinical status in multiple sclerosis: a 1.5 T and 3 T MRI study. J Neurol Sci. (2009) 279:99–105. 10.1016/j.jns.2008.11.009 PubMed DOI PMC

Evangelou N, DeLuca GC, Owens T, Esiri MM. Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions. Brain. (2005) 128(Pt 1):29–34. 10.1093/brain/awh323 PubMed DOI

Losseff NA, Webb SL, O'Riordan JI, Page R, Wang L, Barker GJ, et al. . Spinal cord atrophy and disability in multiple sclerosis. a new reproducible and sensitive MRI method with potential to monitor disease progression. Brain. (1996) 119:701–8. 10.1093/brain/119.3.701 PubMed DOI

Miller DH. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain. (2002) 125(Pt 8):1676–795. 10.1093/brain/awf177 PubMed DOI

Uher T, Krasensky J, Vaneckova M, Sobisek L, Seidl Z, Havrdova E, et al. . A novel semiautomated pipeline to measure brain atrophy and lesion burden in multiple sclerosis: a long-term comparative study. J Neuroimag. (2017) 27:620–9. 10.1111/jon.12445 PubMed DOI

Naismith RT, Xu J, Klawiter EC, Lancia S, Tutlam NT, Wagner JM, et al. . Spinal cord tract diffusion tensor imaging reveals disability substrate in demyelinating disease. Neurology. (2013) 80:2201–9. 10.1212/WNL.0b013e318296e8f1 PubMed DOI PMC

Lorscheider J, Buzzard K, Jokubaitis V, Spelman T, Havrdova E, Horakova D, et al. . Defining secondary progressive multiple sclerosis. Brain. (2016) 139:2395–405. 10.1093/brain/aww173 PubMed DOI

Uher T, Vaneckova M, Sormani MP, Krasensky J, Sobisek L, Blahova Dusankova J, et al. . Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach. Euro J Neurol. (2017) 24:292–301. 10.1111/ene.13200 PubMed DOI

Sormani MP, Arnold DL, De Stefano N. Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis. Annal Neurol. (2014) 75:43–9. 10.1002/ana.24018 PubMed DOI

Eden D. Spatial distribution of multiple sclerosis lesions in the cervical spinal cord. Brain. (2019) 142:633–46. 10.1093/brain/awy352 PubMed DOI PMC

Lukas C, Knol DL, Sombekke DH, Bellenberg B, Hahn HK, Popescu V, et al. . Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis. J Neurol Neurosurg Psychiatry. (2015) 86:410–8. 10.1136/jnnp-2014-308021 PubMed DOI

Petrova N. Axonal loss in the multiple sclerosis spinal cord revisited. Brain Pathol. (2018) 28:334–48. 10.1111/bpa.12516 PubMed DOI PMC

Bergers E, Bot JCJ, De Groot CJA, Polman CH, Lycklama à Nijeholt GJ, van der Valk JAP, et al. . Axonal damage in the spinal cord of MS patients occurs largely independent of T2 MRI lesions. Neurology. (2002) 59, 1766–71. 10.1212/01.WNL.0000036566.00866.26 PubMed DOI

Nijeholt GJ, Bergers E, Kamphorst W, Bot J, Nicolay K, Castelijns JA, et al. . Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis a correlative study with conventional MRI, histopathology and clinical phenotype. Brain. (2001) 124:154–66. 10.1093/brain/124.1.154 PubMed DOI

Combès B, Kerbrat A, Ferré JC, Callot V, Maranzano J, Badji A, et al. . Focal and diffuse cervical spinal cord damage in patients with early relapsing–remitting MS: a multicentre magnetisation transfer ratio study. Multiple Sclerosis J. (2018) 25:1113–23. 10.1177/1352458518781999 PubMed DOI

Coret F, Bosca I, Landete L, Magraner MJ, Navarré A, Leó J, et al. . Early diffuse demyelinating lesion in the cervical spinal cord predicts a worse prognosis in relapsing–remitting multiple sclerosis. Mult Scler. (2010) 16:935–41. 10.1177/1352458510371960 PubMed DOI

Kearney H, Yiannakas MC, Samson RS, Wheeler-Kingshott CAW, Ciccarelli O, Miller DH. (2014). Investigation of magnetization transfer ratio-derived pial and subpial abnormalities in the multiple sclerosis spinal cord. Brain. 137(Pt 9):2456–68. 10.1093/brain/awu171 PubMed DOI

Mohajeri Moghaddam S, Bhatt AA. Location, length, and enhancement: systematic approach to differentiating intramedullary spinal cord lesions. Insights Imag. (2018) 9:511–26. 10.1007/s13244-018-0608-3 PubMed DOI PMC

Sarbu N, Shih RY, Jones RV, Horkayne-Szakaly I, Oleaga L, James G, et al. . White matter diseases with radiologic-pathologic correlation. RadioGraphics. (2016) 36:1426–47. 10.1148/rg.2016160031 PubMed DOI

Sato DK, Callegaro D, Lana-Peixoto MA, Waters PJ, de Haidar Jorge FM, Takahashi T, et al. . Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology. (2014) 82:474–81. 10.1212/WNL.0000000000000101 PubMed DOI PMC

Spadaro M, Gerdes LA, Krumbholz M, Ertl-Wagner B, Thaler FS, Schuh E, et al. . Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. (2016) 3:e257. 10.1212/NXI.0000000000000257 PubMed DOI PMC

Dastagir A, Healy BC, Chua AS, Chitnis T, Weiner HL, Bakshi R, et al. . Brain and spinal cord mri lesions in primary progressive vs. relapsing-remitting multiple sclerosis. eNeurol Sci. (2018) 12:42–6. 10.1016/j.ensci.2018.07.002 PubMed DOI PMC

Mann RS, Constantinescu CS, Tench CR. Upper cervical spinal cord cross-sectional area in relapsing remitting multiple sclerosis: application of a new technique for measuring cross-sectional area on magnetic resonance images. J Magn Resonance Imag. (2007) 26:61–5. 10.1002/jmri.20959 PubMed DOI

Rashid W, Davies GR, Chard DT, Griffin CM, Altmann DR, Gordon R, et al. . Upper cervical cord area in early relapsing-remitting multiple sclerosis: cross-sectional study of factors influencing cord size. J Magn Resonance Imag. (2006) 23:473–6. 10.1002/jmri.20545 PubMed DOI

Oh J, Saidha S, Chen M, Smith SA, Prince J, Jones C, et al. . Spinal cord quantitative MRI discriminates between disability levels in multiple sclerosis. Neurology. (2013) 80:540–7. 10.1212/WNL.0b013e31828154c5 PubMed DOI PMC

Bellenberg B, Busch M, Trampe N, Gold R, Chan A, Lukas C. 1H-magnetic resonance spectroscopy in diffuse and focal cervical cord lesions in multiple sclerosis. Eur Radiol. (2013) 23:3379–92. 10.1007/s00330-013-2942-7 PubMed DOI

Fechner A, Savatovsky J, El Methni J, Sadik JC, Gout O, Deschamps R, et al. . A 3T phase-sensitive inversion recovery MRI sequence improves detection of cervical spinal cord lesions and shows active lesions in patients with multiple sclerosis. Am J Neuroradiol. (2019) 40:370–5. 10.3174/ajnr.A5941 PubMed DOI PMC

Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences

Brainstem lesions are associated with diffuse spinal cord involvement in early multiple sclerosis